A new neutrophil subset promotes CNS neuron survival and axon regeneration.
Andrew R SasKevin S CarbajalAndrew D JeromeRajasree MenonChoya YoonAshley L KalinskiRoman J GigerBenjamin M SegalPublished in: Nature immunology (2020)
Transected axons typically fail to regenerate in the central nervous system (CNS), resulting in chronic neurological disability in individuals with traumatic brain or spinal cord injury, glaucoma and ischemia-reperfusion injury of the eye. Although neuroinflammation is often depicted as detrimental, there is growing evidence that alternatively activated, reparative leukocyte subsets and their products can be deployed to improve neurological outcomes. In the current study, we identify a unique granulocyte subset, with characteristics of an immature neutrophil, that had neuroprotective properties and drove CNS axon regeneration in vivo, in part via secretion of a cocktail of growth factors. This pro-regenerative neutrophil promoted repair in the optic nerve and spinal cord, demonstrating its relevance across CNS compartments and neuronal populations. Our findings could ultimately lead to the development of new immunotherapies that reverse CNS damage and restore lost neurological function across a spectrum of diseases.
Keyphrases
- cerebral ischemia
- optic nerve
- blood brain barrier
- spinal cord injury
- stem cells
- spinal cord
- ischemia reperfusion injury
- subarachnoid hemorrhage
- peripheral blood
- optical coherence tomography
- oxidative stress
- mesenchymal stem cells
- multiple sclerosis
- metabolic syndrome
- white matter
- brain injury
- bone marrow
- traumatic brain injury
- cerebrospinal fluid
- inflammatory response